Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New 'Star Homes' aim to slash childhood disease in tanzania

NCT ID NCT04529434

Prevention Sponsor: University of Oxford Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether specially built houses (Star Homes) could reduce malaria, respiratory infections, and diarrhea in children under 13 in rural Tanzania. Over 1,100 children lived either in a Star Home or a traditional mud house. The Star Homes have screened windows, solar lighting, and outdoor latrines to keep insects and germs out. Researchers tracked how often children got sick over time to see if the house design made a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Star Homes (specially designed houses with screened windows, solar power, and improved sanitation)
What this could lead to
If it works, this could show that better housing design is a simple, lasting way to prevent common childhood diseases in malaria-endemic areas.
What could go wrong
This is a completed study, but results are not yet widely confirmed. The houses are expensive to build, and benefits may not apply to other regions or climates.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,183 people

The number who actually took part.

Started

Jan 2022

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Up to 12 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria Main study * Children, aged under 13 years old, male or female * Residing in a study village for at least 3 years * Parents/guardian is willing and able to give written informed consent for the child to participate in the baseline and end-of study evaluation and the surveillance for malaria, respiratory tract infection and diarrhoeal disease. * Additionally, children 10, 11, and 12 years of age provide assent to participate. Ancillary studies * Head of a household or other family member of a household that is taking part in the main study * 18 years and above * Consent to take part in the main study * Residing and live in the village for 3 years or more * Live in the intervention or comparison houses or a trusted community member (community leaders, medical officer and community health worker) Exclusion criteria Main study * Any participant who refuses, or in the case of children whose parents/guardian refuses, to participate in the study. * Any child who is between 10 and 12 years who refuses to provide assent * If the family plans for moving to other village during the study period * Parents/guardians have mental health problems Ancillary studies * Under 18 years * Not provide consent * Not living in the study village for 3 years or more

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diarrhoea are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute diarrhea diarrheal disease malaria respiratory tract infectious disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diarrhoea;acute Malaria Respiratory tract infection acute

Contacts and locations

Locations

  • CSK Research Solutions

    Dar Es Salaam, Mtwara, Tanzania

More trials for these conditions

Other studies related to the condition(s) this trial covers.